Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion type Assertion NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_head.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion description "[We demonstrated, unexpectedly, opposite outcomes of MK2206 and perifosine in their combinational treatments with BRAF(V600E)/MEK inhibitors in thyroid cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_provenance.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion evidence source_evidence_literature NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_provenance.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion SIO_000772 22090271 NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_provenance.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion wasDerivedFrom befree-2016 NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_provenance.
- NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_assertion wasGeneratedBy ECO_0000203 NP939366.RAy2d5QE-Lqm3yReY8Gq4-sNjn6mLc1Wz2r3Q_4BjdI_8130_provenance.